US Supreme Court to look at what adverse events need to be disclosed to shareholders
This article was originally published in RAJ Devices
Executive Summary
The US Supreme Court has agreed to review Matrixx Initiatives Inc v Siracusano, a case that has the potential to determine which adverse event reports drug and medical device companies must disclose to shareholders to avoid securities suits1.